China Pharma Holdings, Inc.
China Pharma Holdings, Inc. (CPHI) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CPHI · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
China Pharma Holdings, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
CPHI insider buying and selling by quarter
CPHI insider selling · CPHI insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Recent insider transactions
CPHI executive sell shares · CPHI board member insider trading · CPHI insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 29, 2023 | Li Zhilin CEO & Interim CFO · Director | Award | 13,757,063 | $1.93M⚡ | Form 4 |
| Sep 9, 2021 | Li Zhilin CEO & Interim CFO · Director | Award | 1,760,000 | $1.18M⚡ | Form 4 |
| Dec 23, 2020 | Li Zhilin CEO and interim CFO · Director | Award | 2,000,000 | — | Form 4 |
| Apr 28, 2012 | WAUNG FRANK CFO | Award | 100,000 | — | Form 4 |
| May 25, 2011 | Li Zhilin President and CEO · Director | Award | 50,000 | — | Form 4 |
| May 25, 2011 | WAUNG FRANK CFO | Award | 25,000 | — | Form 4 |
| Dec 13, 2010 | WAUNG FRANK CFO | Award | 6,863 | — | Form 4 |
| Nov 15, 2010 | WAUNG FRANK CFO | Option | 4,052 | $12K | Form 4 |
| May 16, 2006 | Tsui Heung Mei Director | Award | 4,723,056 | $5K | Form 4 |
Li Zhilin
CEO & Interim CFO · Director
Date
Sep 29
Shares
13,757,063
Price
$0.14
Value
$1.93M ⚡
Li Zhilin
CEO & Interim CFO · Director
Date
Sep 9
Shares
1,760,000
Price
$0.67
Value
$1.18M ⚡
Li Zhilin
CEO and interim CFO · Director
Date
Dec 23
Shares
2,000,000
Price
—
Value
—
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CPHI insider trading
CPHI insider trades
China Pharma Holdings, Inc. (CPHI) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CPHI. Over the past 12 months, 0 insiders have filed transactions with the SEC. CPHI insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For China Pharma Holdings, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CPHI insider trading · 5 questionsThe insiders of China Pharma Holdings, Inc. (CPHI) include executives and directors such as CPHI, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026